Provided by Tiger Trade Technology Pte. Ltd.

Acumen Pharmaceuticals, Inc.

3.16
-0.0300-0.94%
Post-market: 3.220.0632+2.00%19:30 EDT
Volume:716.03K
Turnover:2.32M
Market Cap:228.19M
PE:-1.93
High:3.34
Open:3.21
Low:3.14
Close:3.19
52wk High:3.60
52wk Low:1.21
Shares:72.21M
Float Shares:37.05M
Volume Ratio:1.45
T/O Rate:1.93%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6370
EPS(LYR):-2.0035
ROE:-120.50%
ROA:-45.77%
PB:3.98
PE(LYR):-1.58

Loading ...

ProMIS Neurosciences Q2 Net Loss Widens

Reuters
·
Aug 14

Citi Remains a Buy on Acumen Pharmaceuticals (ABOS)

TIPRANKS
·
Aug 13

Acumen Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 12

Acumen Pharmaceuticals Posts Corporate Presentation on Sabirnetug Antibody Program for Early Alzheimer’s Disease

Reuters
·
Aug 12

Acumen Pharmaceuticals Q2 EPS $(0.45) Misses $(0.34) Estimate

Benzinga Earnings
·
Aug 12

Acumen Pharmaceuticals Q2 Net Loss Widens, Misses Analyst Estimates

Reuters
·
Aug 12

Acumen Pharmaceuticals, Inc. Q2 Income from Operations USD -32.556 Million Vs. IBES Estimate USD -24.6 Million

Reuters
·
Aug 12

Acumen Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Highlights

THOMSON REUTERS
·
Aug 12

Acumen Pharmaceuticals, Inc. Q2 Basic EPS USD -0.45

THOMSON REUTERS
·
Aug 12

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 11

Acumen Pharmaceuticals Inc Expected to Post a Loss of 37 Cents a Share - Earnings Preview

Reuters
·
Aug 10

Acumen Pharmaceuticals Inc Expected to Post a Loss of 37 Cents a Share - Earnings Preview

Reuters
·
Aug 08

Acumen Pharmaceuticals to Report Second Quarter Financial Results on August 12, 2026

GlobeNewswire
·
Aug 06

Acumen presents new findings at AAIC conference

TIPRANKS
·
Jul 15

Acumen Says EBD Candidate Acu401 Boosts Brain Exposure up to 40-fold in Primate Study

Reuters
·
Jul 15

Acumen Pharmaceuticals - Ebd Bispecific Antibodies Show Improved Brain Penetration Compared to Native Anti-aβo Antibodies

THOMSON REUTERS
·
Jul 15

Acumen Pharmaceuticals - no Hematological Safety Signals Observed for Acu401 in Non-human Primates

THOMSON REUTERS
·
Jul 15

Acumen Pharmaceuticals Highlights Enhanced Brain Delivery™ (EBD™) Program Data and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026

GlobeNewswire
·
Jul 15

Acumen Pharmaceuticals to Present Enhanced Brain Delivery Alzheimer’s Data at AAIC 2026

Reuters
·
Jul 07

Acumen Pharmaceuticals Insider Makes Eye-Catching Stock Move

TIPRANKS
·
Jun 18